![]() |
Advanced Search |
|
Independent Review Board (IRB)/Ethical ReviewAbout RCRC IRB RCRC IRB, established in 1985, oversees research conducted by individual investigators and serves as a central IRB for multi-site national studies. The committee is dedicated to the protection of research participants involved in clinical research trials. The board is established in accordance with the FDA regulations and has the authority to approve, require modifications or disapprove all research activities under its review. RCRC IRB is a member of the Consortium of Independent Review Boards (CIRB) and reviews biomedical research studies in a wide area of therapeutic specialties. Board Composition RCRC IRB is organized and operates in compliance with FDA procedures described in 21 CFR Parts 50 and 56 and the International Conference of Harmonization Good Clinical Practice (ICH GCP) Guidelines. Within these guidelines, our boards adhere to the following:
Board Experience We offer ethical review and guidance in a variety of areas, including:
The board members have expertise in a broad range of specialties, including:
Each board will contract with outside consultants where a specialist is needed. |
|
|||||||||||||||||
|
|||||